VenatoRx Pharmaceuticals Names Lisa Wittmer, Ph.D. Chief Development Officer

By WebmasterApril 4, 2019November 1st, 2024No Comments

VenatoRx Pharmaceuticals Names Lisa Wittmer, Ph.D. Chief Development Officer

Previous PostIView Therapeutics was awarded SBIR Innovative Year 2 Grant by NIH's National Institute of Allergy and Infectious Diseases (NIAID)
Next PostGina DiGuglielmo Joins Relmada as Vice President and Head of Clinical Operations